Cyclacel Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Dec 23 | BuyUS$20,122 | Spiro Rombotis | Individual | 6,070 | US$3.32 | |
21 Dec 23 | BuyUS$6,252 | Paul McBarron | Individual | 1,886 | US$3.32 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 807 | 0.0612% |
Hedge Funds | 82,032 | 6.22% |
Individual Insiders | 93,840 | 7.12% |
Institutions | 170,840 | 13% |
General Public | 970,738 | 73.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 57.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
102,250 | US$163.6k | 21.4% | 0.65% | |||
82,032 | US$131.3k | 116% | 0.08% | |||
29,603 | US$47.4k | 6.01% | no data | |||
24,223 | US$38.8k | 0% | no data | |||
16,680 | US$26.7k | 301% | no data | |||
16,056 | US$25.7k | 5.96% | no data | |||
15,333 | US$24.5k | 0% | no data | |||
14,438 | US$23.1k | 16.8% | no data | |||
12,630 | US$20.2k | 4.6% | no data | |||
5,796 | US$9.3k | 0% | no data | |||
5,761 | US$9.2k | 0% | no data | |||
4,181 | US$6.7k | 0.46% | no data | |||
4,155 | US$6.6k | -0.14% | no data | |||
4,089 | US$6.5k | -0.12% | no data | |||
4,073 | US$6.5k | -0.1% | no data | |||
2,373 | US$3.8k | 68.8% | no data | |||
1,900 | US$3.0k | 0.37% | no data | |||
832 | US$1.3k | -0.12% | no data | |||
807 | US$1.3k | 238% | no data | |||
126 | US$201.6 | -73.5% | no data | |||
80 | US$128.0 | 0% | no data | |||
33 | US$52.7 | 0% | no data | |||
25 | US$40.1 | -92% | no data | |||
20 | US$32.1 | 0% | no data | |||
13 | US$20.9 | 0% | no data |